What is Lasa Supergenerics share price return in the past 10 years?

Data is not available for this company

Lasa Supergenerics Ltd - Stock Valuation and Financial Performance

Name: Lasa Supergenerics
Brand: Lasa Supergenerics

BSE: 540702 | NSE: LASA | Pharmaceuticals & Drugs | Small Cap

Place order

Lasa Supergenerics Share Price

₹11.55 -0.60 -4.94%
as on 17-Jun'25 16:59

DeciZen - make an informed investing decision on Lasa Supergenerics

Based on:

Data

M-Cap below 100cr DeciZen not available

asa Supergenerics stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

60.9 Cr.

52-wk low:

11.9

52-wk high:

33.5

Is Lasa Supergenerics Ltd an attractive stock to invest in?

1. Is Lasa Supergenerics Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Lasa Supergenerics Ltd is a below average quality company.

2. Is Lasa Supergenerics Ltd undervalued or overvalued?

The key valuation ratios of Lasa Supergenerics Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Lasa Supergenerics Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Lasa Supergenerics Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Lasa Supergenerics:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	0%	0%	14.5%	12.8%	-3.7%	6.8%	17.1%	-3.4%	-23.9%	-13.2%	-
Value Creation Index ⓘ	NA	NA	0.0	-0.1	-1.3	-0.5	0.2	-1.2	-2.7	-2.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	199	244	170	167	202	137	130	104	142
Sales YoY Gr.	-	NA	NA	22.5%	-30.4%	-1.4%	21%	-32.2%	-5.5%	-19.5%	-
Adj EPS ⓘ	0	0	501.5	5.4	-5.2	1	5.6	0.1	-4.8	-3.1	-3
YoY Gr.	-	NA	NA	-98.9%	-196.7%	NA	475.3%	-97.9%	-4091.7%	NA	-
BVPS (₹) ⓘ	0	-60.2	10,983.3	51.3	46.1	34.8	39.1	31.5	23.6	19.3	16.7
Adj Net Profit ⓘ	0	0	2.5	12.3	-11.9	4	22.7	0.6	-24	-15.6	-15
Cash Flow from Ops. ⓘ	0	-0.4	-3	40.4	40.7	13.6	41.3	9.2	-17.3	2.1	-
Debt/CF from Ops. ⓘ	0	-1	-38.6	2.6	2.1	3.6	0.5	2.2	-1.3	10.3	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	-9.3%	-19.8%	-19.5%
Adj EPS ⓘ	NA	NA	-182.3%	NA
BVPSⓘ	NA	-16%	-21%	-18.3%
Share Price	-	-23.4%	-30.5%	-51.3%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	0	6.6	12.8	-10.7	3.2	15.1	0.4	-17.4	-14.5	-16.4
Op. Profit Mgn % ⓘ	0	23	16.9	6.7	18.2	23.3	12.3	-3.6	2.2	4.8
Net Profit Mgn % ⓘ	0	1.3	5.1	-7	2.4	11.2	0.5	-18.5	-14.9	-10.4
Debt to Equity ⓘ	-1.2	2.1	0.9	0.8	0.3	0.1	0.1	0.2	0.2	0
Working Cap Days ⓘ	0	66	138	206	169	118	147	123	130	41
Cash Conv. Cycle ⓘ	0	27	53	39	0	18	41	33	29	4

Recent Performance Summary

Sales growth is good in last 4 quarters at 39.67%

Return on Equity is Poor

Sales growth has been subdued in last 3 years -19.81%

Latest Financials - Lasa Supergenerics Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-3	-
TTM Sales (₹ Cr.)	142	-
BVPS (₹.) ⓘ	16.7	-
Reserves (₹ Cr.) ⓘ	34	-
P/BV ⓘ	0.73	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	11.93 / 33.49
All Time Low / High (₹)	9.48 / 214.90
Market Cap (₹ Cr.)	60.9
Equity (₹ Cr.)	50.1
Face Value (₹)	10
Industry PE ⓘ	41.7

Management X-Ray of Lasa Supergenerics:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

31.19

20.66

20.71

20.66

* Pledged shares as % of Promoter's holding (%)

Valuation of Lasa Supergenerics

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

No data found!

Key Ratios of Lasa Supergenerics

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	0	198.75	243.53	169.57	167.26	202.38	137.13	129.57	104.34
Operating Expenses ⓘ	0	153.23	202.26	158.52	137.29	155.17	121.11	136.17	102.11
Manufacturing Costs	0	9.56	13.92	12.68	15.75	17.51	12.40	13.93	15.33
Material Costs	0	130.89	171.51	127.95	94.65	112.35	91.29	106.11	75.22
Employee Cost	0	9.55	10.27	11.74	13.42	14.01	7.15	6.35	5.37
Other Costs ⓘ	0	3.23	6.56	6.16	13.47	11.30	10.27	9.77	6.20
Operating Profit ⓘ	0	45.52	41.26	11.05	29.97	47.21	16.02	-6.60	2.22
Operating Profit Margin (%)	-	22.9%	16.9%	6.5%	17.9%	23.3%	11.7%	-5.1%	2.1%
Other Income ⓘ	0	2.17	3.49	0.54	0.23	0.18	0.28	1.84	0.10
Interest ⓘ	0	11.68	11.35	8.38	8.12	2.06	0.06	4.19	1.99
Depreciation ⓘ	0	7.69	18.17	19.31	17.34	15.82	14.51	13.42	10.67
Exceptional Items ⓘ	0	-26.19	0	0	0	0	-7.86	-19.90	-8.77
Profit Before Tax ⓘ	0	2.14	15.23	-16.10	4.74	29.49	-6.14	-42.27	-19.11
Tax ⓘ	0	-0.22	2.89	-4.07	1.11	6.71	-0.81	-3.64	2.62
Profit After Tax	0	2.36	12.34	-12.03	3.63	22.78	-5.33	-38.62	-21.73
PAT Margin (%)	-	1.2%	5.1%	-7.1%	2.2%	11.3%	-3.9%	-29.8%	-20.8%
Adjusted EPS (₹)	0.0	472.5	5.4	-5.3	0.9	5.6	-1.1	-7.7	-4.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	4%	-23%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	0.05	54.92	117.34	105.30	141.47	158.92	157.88	118.29	96.68
Share Capital ⓘ	0.05	0.05	22.86	22.86	40.67	40.67	50.10	50.10	50.10
Reserves ⓘ	0	54.87	94.48	82.43	100.79	118.24	107.78	68.18	46.58
Minority Interest	0	0	0	0	0	0	0	0	0
Debt	0.35	103.87	90.10	68.73	34.48	0	0	0	0
Long Term Debt	0.35	80.68	60.27	45.72	14.14	0	0	0	0
Short Term Debt	0	23.19	29.83	23	20.34	0	0	0	0
Trade Payables	0	25.38	47.94	59.67	33.73	12.72	16.91	9.43	14.05
Others Liabilities ⓘ	0	44.08	31.40	21.78	19.14	36.22	34.38	36.14	40.14
Total Liabilities ⓘ	0.40	228.25	286.78	255.47	228.81	207.86	209.17	163.85	150.87
Fixed Assets
Gross Block	0	131.61	200.58	211.87	219.54	226.12	233.77	228.70	230.18
Accumulated Depreciation	0	12.78	30.94	50.17	67.35	83.17	96.49	109.74	120.42
Net Fixed Assetsⓘ	0	118.83	169.64	161.69	152.19	142.95	137.28	118.96	109.76
CWIP ⓘ	0	29.51	7.24	7.21	0	0	4.58	4.64	2.51
Investmentsⓘ	0	0	0	0	0	0	0.38	0.39	0
Inventories	0	33.46	42.23	31.60	26.30	17.26	11.50	13.90	19.04
Trade Receivables	0	34.97	42.15	28.88	20.65	14.77	18.56	2.48	3.59
Cash Equivalents	0.05	1.16	2.63	2.69	6.06	4.40	17.22	2.39	1.50
Others Assetsⓘ	0.35	10.31	22.88	23.41	23.61	28.48	19.66	21.09	14.47
Total Assets ⓘ	0.40	228.25	286.78	255.47	228.81	207.86	209.17	163.85	150.87

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	-0.35	-3	40.35	40.66	13.62	41.31	9.21	-17.30	2.14
PBT ⓘ	0	2.14	15.23	-16.10	4.74	29.49	1.72	-22.37	-19.11
Adjustment ⓘ	0	17.33	26.07	27.20	25.27	17.75	6.50	-4.07	8.42
Changes in Working Capital ⓘ	-0.35	-22.14	1.34	33.11	-16.01	-5.93	3.59	9.18	12.83
Tax Paid ⓘ	0	-0.33	-2.30	-3.54	-0.37	0	-2.59	-0.04	0
Cash Flow From Investing Activity ⓘ	0	0.38	-44.41	-7.34	-1.63	-3.60	-2.91	11.19	-0.40
Capex	0	-1.69	-46.71	-11.33	-0.63	-6.59	2.58	4.83	0.66
Net Investments	0	0	-1.12	-0.13	-1.23	2.93	-5.59	4.56	1.09
Others ⓘ	0	2.07	3.41	4.12	0.23	0.06	0.10	1.80	-2.15
Cash Flow From Financing Activityⓘ	0.40	0.05	4.41	-33.40	-9.85	-36.44	-0.04	-4.16	-1.93
Net Proceeds from Shares ⓘ	0.05	0	29.52	0	32.50	0	0	0	0
Net Proceeds from Borrowing ⓘ	0.35	6.18	-20.41	-14.55	-31.58	-14.14	0	0	0
Interest Paid ⓘ	0	-11.68	-11.34	-12.02	-8.10	-1.96	-0.04	-4.16	-1.93
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0
Others ⓘ	0	5.55	6.65	-6.83	-2.67	-20.34	0	0	0
Net Cash Flow ⓘ	0.05	-2.57	0.35	-0.08	2.15	1.27	6.26	-10.27	-0.19

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	0	8.65	14.33	-10.81	2.94	15.17	-3.37	-27.97	-20.22
ROCE (%)	0	14.45	12.8	-3.73	6.77	17.14	-3.41	-23.94	-13.23
Asset Turnover Ratio	0	1.91	0.95	0.63	0.69	0.93	0.66	0.69	0.66
PAT to CFO Conversion(x)	N/A	-1.27	3.27	N/A	3.75	1.81	N/A	N/A	N/A
Working Capital Days
Receivable Days	0	58	57	76	54	32	44	30	11
Inventory Days	0	56	56	79	63	39	38	36	58
Payable Days	0	71	78	153	180	75	59	45	57

Lasa Supergenerics Ltd Stock News

Lasa Supergenerics Ltd FAQs

What is the share price of Lasa Supergenerics?

Company share prices are keep on changing according to the market conditions. The closing price of Lasa Supergenerics on 17-Jun-2025 16:59 is ₹11.55.

What is the market cap of Lasa Supergenerics?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 17-Jun-2025 16:59 the market cap of Lasa Supergenerics stood at ₹60.87.

What is the P/E ratio of Lasa Supergenerics?

The latest P/E ratio of Lasa Supergenerics as of 17-Jun-2025 16:59 is 0.00.

What is the P/B ratio of Lasa Supergenerics?

The latest P/B ratio of Lasa Supergenerics as of 17-Jun-2025 16:59 is 0.73.

What is the 52-week high and low of Lasa Supergenerics?

The 52-week high of Lasa Supergenerics is ₹33.49 and the 52-week low is ₹11.93.

What is the TTM revenue of Lasa Supergenerics?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Lasa Supergenerics is ₹142.4 ( Cr.) .

About Lasa Supergenerics Ltd

No data to display

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

SEBI Registered: Investment Adviser - INA000013323 RIA Details

Warning: Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Disclaimer: Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provides any assurance of returns to investors.

Compliance Officer:

Name: Shrikant Jagtap

Email: shrikant.jagtap@moneyworks4me.com

Mobile No: +91 97638 00745

Grievance Officer:

Name: Mukta Vaze

Email: mukta.vaze@moneyworks4me.com

Mobile No:+91 98609 19463

Principal Officer:

Name: Atharva Bhide

Email: atharva.bhide@moneyworks4me.com

Mobile No:+91 91758 99463

SEBI regional/local office address-

Plot No. C 4-A , G Block, Near Bank of India, Bandra Kurla Complex, Bandra East, Mumbai, Maharashtra 400051

Address:

The Alchemists Ark Pvt. Ltd., B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Data provided by Accord Fintech Pvt. Ltd.

Please wait your portfolio is updating...

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity - May 16, 2019 - Perpetual
BASL Membership ID:	BASL1187
Address	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Lasa Supergenerics Ltd - Stock Valuation and Financial Performance

Lasa Supergenerics Share Price

DeciZen - make an informed investing decision on Lasa Supergenerics Share

M-Cap below 100cr DeciZen not available

asa Supergenerics stock performance -

Is Lasa Supergenerics Ltd an attractive stock to invest in?

1. Is Lasa Supergenerics Ltd a good quality company?

2. Is Lasa Supergenerics Ltd undervalued or overvalued?

3. Is Lasa Supergenerics Ltd a good buy now?

10 Year X-Ray of Lasa Supergenerics: Share

Analysis of Financial Track Record

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Recent Performance Summary

Latest Financials - Lasa Supergenerics Ltd.

Management X-Ray of Lasa Supergenerics: Share

Shareholding Pattern

Promoter's Holding & Share Pledging